Monashee Investment Management’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-120,000
Closed -$1.27M 87
2023
Q2
$1.27M Buy
+120,000
New +$1.42M 0.3% 52
2021
Q1
Sell
-115,000
Closed -$3.76M 404
2020
Q4
$3.76M Buy
+115,000
New +$4.04M 0.5% 44
2019
Q3
Sell
-235,956
Closed -$4.65M 154
2019
Q2
$4.65M Buy
+235,956
New +$3.92M 1.2% 20
2018
Q2
Hold
0
49
2016
Q1
Sell
-65,222
Closed -$309K 22
2015
Q4
$548K Buy
+65,222
New +$513K 1.09% 23

Other funds holding KURA

Monashee Investment Management's KURA Position: Q3 2023 in Review

Monashee Investment Management sold out of Kura Oncology (KURA) in Q3 2023, closing a stake of 120,000 shares — an estimated $1.27M sold.

Monashee Investment Management first reported a position in KURA in Q4 2015 and held it in 4 quarters. The position peaked at $4.65M in Q2 2019. 133 funds tracked by Wall St. Rank hold KURA as of Q3 2023.

  • Monashee Investment Management reported no remaining Kura Oncology position as of Q3 2023 after selling out during the quarter.
  • Monashee Investment Management sold 120,000 Kura Oncology shares in Q3 2023, an estimated $1.27M.
  • Monashee Investment Management first reported a position in Kura Oncology in Q4 2015 and held it in 4 quarters.
  • Monashee Investment Management's Kura Oncology position peaked at $4.65M in Q2 2019.
  • 133 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2023.

Based on Monashee Investment Management's 13F filing for Q3 2023, filed 13 Nov 2023.